Petros Grivas MD

Clinical Lecturer, Hematology & Oncology
Internal Medicine, Hematology & Oncology
Clinical Interests:

Cancers of the genitourinary organs, including kidney, urothelial (bladder), prostate, testis



Medical School or Training

  • University of Patras, 2005


  • Drexel University (formerly MCP Hahnemann University), Internal Medicine, PA, 2010


  • Internal Medicine Hematology Oncology, University of Michigan Health System, 2013

Professional Organizations

  • American Society of Clinical Oncology (ASCO)

  • American Association for Cancer Research (AACR)

  • Southwest Oncology Group (SWOG)

  • American College of Physicians (ACP)

Board Certification

  • Internal Medicine

  • Medical Oncology


Clinical and translational research on experimental therapeutics in bladder and prostate cancer, via a molecular biology-based approach in the laboratory aiming to translate results into clinical trials. Working in the laboratory in the Translational Oncology Program (T.O.P.) with preclinical human models of bladder cancer focusing on targeted therapies, and especially Human Epidermal Receptor (HER) targeting. Currently involved in early phase clinical trials (urothelial and prostate cancer, and participating in the Bladder Cancer Program (University of Michigan, a multidisciplinary, comprehensive research group focusing on bladder cancer research